The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Y Huang, W Hong, X Wei - Journal of hematology & oncology, 2022 - Springer
Epithelial–mesenchymal transition (EMT) is an essential process in normal embryonic
development and tissue regeneration. However, aberrant reactivation of EMT is associated …
development and tissue regeneration. However, aberrant reactivation of EMT is associated …
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds
HL Ang, CD Mohan, MK Shanmugam… - Medicinal research …, 2023 - Wiley Online Library
Epithelial‐mesenchymal transition (EMT) is a complex process with a primordial role in
cellular transformation whereby an epithelial cell transforms and acquires a mesenchymal …
cellular transformation whereby an epithelial cell transforms and acquires a mesenchymal …
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
MicroRNAs (miRNAs) are small, non-coding RNAs that post-transcriptionally regulate gene
expression by binding to specific mRNA targets and promoting their degradation and/or …
expression by binding to specific mRNA targets and promoting their degradation and/or …
Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles
Cholangiocarcinoma (CCA) is an aggressive malignancy of the bile ducts, with poor
prognosis and limited treatment options. Here, we describe the integrated analysis of …
prognosis and limited treatment options. Here, we describe the integrated analysis of …
Molecular mechanisms of epithelial–mesenchymal transition
The transdifferentiation of epithelial cells into motile mesenchymal cells, a process known as
epithelial–mesenchymal transition (EMT), is integral in development, wound healing and …
epithelial–mesenchymal transition (EMT), is integral in development, wound healing and …
Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets
The majority of the human genome is not translated into proteins but can be transcribed into
RNA. Even though the resulting non-coding RNAs (ncRNAs) do not encode for proteins …
RNA. Even though the resulting non-coding RNAs (ncRNAs) do not encode for proteins …
Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response
Background and aims Hepatocellular carcinomas (HCCs) are heterogeneous aggressive
tumors with low rates of response to treatment at advanced stages. We screened a large …
tumors with low rates of response to treatment at advanced stages. We screened a large …
Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB
Growing evidence links tumor progression with chronic inflammatory processes and
dysregulated activity of various immune cells. In this study, we demonstrate that various …
dysregulated activity of various immune cells. In this study, we demonstrate that various …
The regulatory role of microRNAs in EMT and cancer
A Zaravinos - Journal of oncology, 2015 - Wiley Online Library
The epithelial to mesenchymal transition (EMT) is a powerful process in tumor invasion,
metastasis, and tumorigenesis and describes the molecular reprogramming and phenotypic …
metastasis, and tumorigenesis and describes the molecular reprogramming and phenotypic …
Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function
H Xu, X Du, J Xu, Y Zhang, Y Tian, G Liu, X Wang… - PLoS …, 2020 - journals.plos.org
Type 2 diabetes (T2D) is characterized by insulin resistance along with pancreatic β cell
failure. β cell factors are traditionally thought to control glucose homeostasis by modulating …
failure. β cell factors are traditionally thought to control glucose homeostasis by modulating …